Drawing for EMHANCE

USPTO serial 79406384

EMHANCE

Reviewed by CopyMark Law Group

Reg. 7988999Status 700Registered
Filing date
Status date
Registration date
Oct 21, 2025
Examiner
CORWIN, CHARLOTTE K
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EMHANCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephen P. McNamara

Stephen P. McNamara St. Onge Steward Johnston & Reens LLC857 Post Road, Ste 398Fairfield, CT 06824-6041United States

Goods and services

ClassDescriptionStatusFirst use
010Electrodes for medical use; medical equipment accessories, namely, electrodiagnostic automated constant current sinusoid waveform neuroselective sensory nerve testing devices, namely, disposable electrodes; electronic nerve stimulators for medical purposes; electronic stimulation apparatus for nerves and muscles for physical therapy purposes; electronic muscle stimulators for medical purposes; medical electrodes; medical apparatus and instruments, namely low-frequency electromagnetic field emitters and cellular electric current sensors for use in non-invasive neurosurgical procedures and neurology; electrotherapy devices for providing transcutaneous electrical nerve stimulation, infrared heat and compression; medical devices, namely, minimally invasive neurovascular devices for the treatment of neurological conditions; nerve stimulator apparatus; body rehabilitation apparatus for medical purposes; high frequency electromagnetic therapy apparatus; low frequency electromagnetic therapy apparatus; medical devices, namely, pulse generators for neurostimulation; electrical stimulation apparatus for nerves for physical therapy, rehabilitative and pain management purposes; non-invasive electronic neuromodulator device for medical use by healthy and impaired persons to enhance performance on cognitive tasks; medical apparatus and instruments relating to neurovegetative reactivity; medical device for accessing subcutaneous structures of the human body for the purpose of administering medical treatment; medical devices for use in treating or diagnosing disorders and diseases of the nervous system; medical devices for use in treating or diagnosing multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, dementias, epilepsy, traumatic brain injuries and stroke; medical devices for use in treating or diagnosing diseases and disorders of the nervous system with integrated recorded operating system software, sold as a unit; medical instruments for measuring and displaying the electromagnetic signals produced by internal bodily organs and tissues; medical imaging apparatusACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 21, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 30, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 30, 2026FIMPFINAL DISPOSITION PROCESSED—
Mar 26, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 9, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 9, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 21, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 21, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 21, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 2, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 2, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 27, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 4, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 31, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 31, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 31, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2025RFNTREFUSAL PROCESSED BY IB—
Feb 4, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 4, 2025RFRRREFUSAL PROCESSED BY MPU—
Dec 31, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 30, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2024DOCKASSIGNED TO EXAMINER—
Oct 16, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 16, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 16, 2024LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Oct 10, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance